CELLUVISC Eye drops, solution Ref.[6361] Active ingredients: Carmellose

Source: Medicines & Healthcare Products Regulatory Agency (GB)  Revision Year: 2014  Publisher: Allergan Pharmaceuticals Ireland, Castlebar Road, Westport, County Mayo, Ireland

Product name and form

Celluvisc 0.5% w/v, eye drops, solution, unit dose.

Pharmaceutical Form

Eye drops, solution in single-dose container.

Clear, colourless to slightly yellow solution.

Qualitative and quantitative composition

1 ml contains 5mg carmellose sodium.

For the full list of excipients, see section 6.1.

Active Ingredient

Carmellose sodium has no pharmacological effect. Carmellose sodium has a high viscosity resulting in an increased retention time on the eye.
List of Excipients

Sodium chloride
Sodium lactate
Potassium chloride
Calcium chloride dihydrate
Magnesium chloride hexahydrate
Sodium hydroxide or hydrochloric acid (for pH adjustment)
Purified water

Pack sizes and marketing

0.4 ml in LDPE single-dose container.

Pack sizes: 5, 30 or 90 single-dose containers.

Not all pack sizes may be marketed.

Marketing authorization holder

Allergan Pharmaceuticals Ireland, Castlebar Road, Westport, County Mayo, Ireland

Marketing authorization dates and numbers

PL 41443/0011

21/05/2010

Drugs

Drug Countries
CELLUVISC Australia, Germany, Finland, France, Hong Kong, Ireland, Netherlands, Tunisia, United Kingdom, South Africa
 
Next: Usage >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈